A new tablet formulation of SMA treatment Evrysdi (risdiplam) may give patients more "freedom and independence," a Genentech ...
Post-COVID, cases of the debilitating syndrome have surged five-fold—here’s what experts and patients want you to know.
Cornell research could rebrand bone as an extension of the nervous system and reshape the understanding of its cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback